These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27935232)

  • 1. Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.
    Marshall EM; Bertaut A; Desmoulins I; Darut-Jouve A; Ponnelle T; Poillot ML; Beltjens F; Arveux P
    Breast J; 2017 Mar; 23(2):138-145. PubMed ID: 27935232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.
    Foukakis T; Fornander T; Lekberg T; Hellborg H; Adolfsson J; Bergh J
    Breast Cancer Res Treat; 2011 Nov; 130(2):553-60. PubMed ID: 21617918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for survival in metastatic breast cancer by hormone receptor status.
    Kwast AB; Voogd AC; Menke-Pluijmers MB; Linn SC; Sonke GS; Kiemeney LA; Siesling S
    Breast Cancer Res Treat; 2014 Jun; 145(2):503-11. PubMed ID: 24771049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis.
    Tjokrowidjaja A; Lee CK; Houssami N; Lord S
    Intern Med J; 2014 Aug; 44(8):764-70. PubMed ID: 24863750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for male breast cancer: similarity to female counterparts.
    Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Au J; Younus J; Perera F; Tai P
    Anticancer Res; 2013 May; 33(5):2227-31. PubMed ID: 23645780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status.
    Bertaut A; Mounier M; Desmoulins I; Guiu S; Beltjens F; Darut-Jouve A; Ponnelle T; Arnould L; Arveux P
    Eur J Cancer Care (Engl); 2015 Nov; 24(6):920-8. PubMed ID: 25757548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.
    Dabakuyo TS; Bonnetain F; Roignot P; Poillot ML; Chaplain G; Altwegg T; Hedelin G; Arveux P
    Ann Oncol; 2008 Feb; 19(2):276-83. PubMed ID: 17962200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
    La Verde N; Collovà E; Blasi L; Pinotti G; Palumbo R; Bonotto M; Garrone O; Brunello A; Rimanti A; Bareggi C; Zaniboni A; Frassoldati A; Foglietta J; Berardi R; Moretti A; Farina G; Porcu L; Barni S
    Clin Breast Cancer; 2021 Oct; 21(5):e489-e496. PubMed ID: 33342749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival.
    Rossi M; Carioli G; Bonifazi M; Zambelli A; Franchi M; Moja L; Zambon A; Corrao G; La Vecchia C; Zocchetti C; Negri E
    Eur J Cancer; 2016 Jan; 52():41-9. PubMed ID: 26630533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Prognostic Factor Index Among Women With HR
    Vidal GA; Carter GC; Gilligan AM; Saverno K; Zhu YE; Price GL; DeLuca A; Smyth EN; Rybowski S; Huang YJ; Schwartzberg LS
    Clin Breast Cancer; 2021 Aug; 21(4):317-328.e7. PubMed ID: 33678566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic breast cancer: are we treating the same patients as in the past?
    Ufen MP; Köhne CH; Wischneswky M; Wolters R; Novopashenny I; Fischer J; Constantinidou M; Possinger K; Regierer AC
    Ann Oncol; 2014 Jan; 25(1):95-100. PubMed ID: 24276026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis.
    Lord SJ; Marinovich ML; Patterson JA; Wilcken N; Kiely BE; Gebski V; Crossing S; Roder DM; Gattellari M; Houssami N
    Med J Aust; 2012 Jun; 196(11):688-92. PubMed ID: 22708766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
    Todorovic-Rakovic N; Neskovic-Konstantinovic Z
    J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
    den Brok WD; Speers CH; Gondara L; Baxter E; Tyldesley SK; Lohrisch CA
    Breast Cancer Res Treat; 2017 Feb; 161(3):549-556. PubMed ID: 28000014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
    Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
    PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
    Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
    BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
    Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
    BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.